1. Home
  2. TRDA vs STRT Comparison

TRDA vs STRT Comparison

Compare TRDA & STRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TRDA

Entrada Therapeutics Inc.

HOLD

Current Price

$10.88

Market Cap

404.4M

Sector

Health Care

ML Signal

HOLD

Logo STRATTEC SECURITY CORPORATION

STRT

STRATTEC SECURITY CORPORATION

HOLD

Current Price

$90.41

Market Cap

331.1M

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRDA
STRT
Founded
2016
1908
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Auto Parts:O.E.M.
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
404.4M
331.1M
IPO Year
2021
1995

Fundamental Metrics

Financial Performance
Metric
TRDA
STRT
Price
$10.88
$90.41
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$20.00
N/A
AVG Volume (30 Days)
246.9K
42.6K
Earning Date
03-06-2026
02-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
64.90
EPS
N/A
6.59
Revenue
$61,520,000.00
$586,028,000.00
Revenue This Year
N/A
$4.15
Revenue Next Year
$21.02
$4.12
P/E Ratio
N/A
$13.23
Revenue Growth
N/A
6.01
52 Week Low
$4.93
$31.57
52 Week High
$13.82
$92.50

Technical Indicators

Market Signals
Indicator
TRDA
STRT
Relative Strength Index (RSI) 52.05 58.47
Support Level $10.48 $86.19
Resistance Level $11.41 $92.50
Average True Range (ATR) 0.74 4.44
MACD -0.06 0.41
Stochastic Oscillator 54.08 72.11

Price Performance

Historical Comparison
TRDA
STRT

About TRDA Entrada Therapeutics Inc.

Entrada Therapeutics Inc is a clinical-stage biopharmaceutical company. It aims to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient intracellular delivery into a variety of organs and tissues, resulting in an improved therapeutic index and protein-based programs for the potential treatment of neuromuscular and ocular diseases, among others. Its oligonucleotide programs are in development for the potential treatment of people living with Duchenne, which are exon 44, 45, 50, and 51 skipping amenable. It has partnered to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1.

About STRT STRATTEC SECURITY CORPORATION

Strattec Security Corp designs develops, manufactures, and markets mechanical locks, electronically enhanced locks, and keys. It also produces ignition lock housings; and access control products, including latches, power sliding door systems, and door handles. Strattec ships products to customer locations in the United States, Canada, Mexico, Europe, South America, Korea, and China, and provides full-service aftermarket support. Strattec also supplies products for the heavy truck and recreational vehicle markets, as well as precision, die castings.

Share on Social Networks: